Lipomatous Tumors: A Comparison of MRI-Reported Diagnosis with Histological Diagnosis.
MRI
atypical lipomatous tumor
lipoma
liposarcoma
sarcoma
soft tissue tumor
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
21 May 2022
21 May 2022
Historique:
received:
15
03
2022
revised:
10
05
2022
accepted:
18
05
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Lipomatous tumors are among the most common soft tissue tumors (STTs). Magnetic resonance imaging (MRI) is a state-of-the-art diagnostic tool used to differentiate and characterize STTs. Radiological misjudgment can lead to incorrect treatment. This was a single-center retrospective study. Two hundred and forty lipomatous tumors were included. MRI diagnoses were categorized as benign, intermediate, or malignant and were compared with histological diagnoses. Tumor volumes were measured by MRI and from surgical specimens. The tumor was correctly categorized 73.3% of the time. A total of 21.7% of tumors were categorized as more malignant in MRI reports than they were by histology, and vice versa for 5.0% of tumors. Volume measured by MRI was not different from actual tumor size in pathology. Atypical lipomatous tumors (ALTs) and liposarcomas (LPSs) were larger when compared with lipomata and occurred in older patients. Based on the MRI-suspected tumor entity, surgical treatment can be planned. Large lipomatous tumors in elderly patients are more likely to be ALTs. However, a safe threshold size or volume for ALTs cannot be determined.
Identifiants
pubmed: 35626435
pii: diagnostics12051281
doi: 10.3390/diagnostics12051281
pmc: PMC9141562
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cancer Imaging. 2020 Oct 28;20(1):78
pubmed: 33115533
Eur J Radiol. 2004 Jun;50(3):257-67
pubmed: 15145485
Dtsch Arztebl Int. 2008 Jul;105(27):492-7
pubmed: 19626189
Sarcoma. 2002;6(1):19-26
pubmed: 18521342
Sarcoma. 2020 Jan 7;2020:7163453
pubmed: 31997918
Dermatol Surg. 2018 Aug;44(8):1065-1069
pubmed: 29659409
Mo Med. 2017 Jul-Aug;114(4):289-294
pubmed: 30228613
Acad Radiol. 2017 May;24(5):615-622
pubmed: 28117119
Bone Joint J. 2020 Aug;102-B(8):1088-1094
pubmed: 32731827
Oncotarget. 2019 Mar 29;10(25):2462-2474
pubmed: 31069009
Sarcoma. 2013;2013:982784
pubmed: 24385845
Clin Radiol. 2008 Apr;63(4):373-8; discussion 379-80
pubmed: 18325355
Am J Surg Pathol. 2007 Oct;31(10):1476-89
pubmed: 17895748
Clin Orthop Relat Res. 2008 Dec;466(12):3093-100
pubmed: 18818981
Radiographics. 2016 May-Jun;36(3):753-66
pubmed: 27163592
In Vivo. 2017 May-Jun;31(3):387-395
pubmed: 28438867
Cancer Res. 2007 Jul 15;67(14):6626-36
pubmed: 17638873
Cancer Epidemiol. 2019 Apr;59:258-264
pubmed: 30870746
Am J Surg Pathol. 2007 Jan;31(1):1-14
pubmed: 17197914
Eur J Surg Oncol. 2005 May;31(4):443-8
pubmed: 15837054
BMC Cancer. 2018 Oct 17;18(1):991
pubmed: 30333006
Skeletal Radiol. 2013 May;42(5):635-47
pubmed: 22987247
Mod Pathol. 2001 Mar;14(3):179-84
pubmed: 11266523
J Clin Oncol. 2016 Mar 10;34(8):786-93
pubmed: 26371143
J Oncol Pract. 2016 Mar;12(3):221-7
pubmed: 26962163
EFORT Open Rev. 2020 Nov 13;5(11):799-814
pubmed: 33312707
Radiographics. 2000 Jul-Aug;20(4):1007-19
pubmed: 10903690
JCO Oncol Pract. 2020 Oct;16(10):e1143-e1150
pubmed: 33049178
Ann Surg. 2007 Jun;245(6):952-8
pubmed: 17522521
Dtsch Arztebl Int. 2009 Sep;106(39):632-6
pubmed: 19890408
J Int Med Res. 2020 Dec;48(12):300060520975882
pubmed: 33296604
Acta Radiol. 1994 Jul;35(4):367-70
pubmed: 8011387
J Musculoskelet Neuronal Interact. 2019 Mar 1;19(1):123-126
pubmed: 30839311
Sarcoma. 2010;2010:702573
pubmed: 21048999
Ann Oncol. 2013 Jul;24(7):1924-1930
pubmed: 23493135
AJR Am J Roentgenol. 1997 Aug;169(2):589-94
pubmed: 9242783
Semin Musculoskelet Radiol. 2015 Dec;19(5):475-82
pubmed: 26696086
Bone Joint J. 2018 Nov;100-B(11):1518-1523
pubmed: 30418059